| 1 |
Portilla-martínez A, Ortiz-flores M, Hidalgo I, Gonzalez-ruiz C, Meaney E, Ceballos G, Nájera N. In silico evaluation of flavonoids as potential inhibitors of SARS-CoV-2 main nonstructural proteins (Nsps)—amentoflavone as a multitarget candidate. J Mol Model 2022;28:404. [DOI: 10.1007/s00894-022-05391-6] [Reference Citation Analysis]
|
| 2 |
Monteiro M, Dias ACP, Costa D, Almeida-dias A, Criado MB. Hypericum perforatum and Its Potential Antiplatelet Effect. Healthcare 2022;10:1774. [DOI: 10.3390/healthcare10091774] [Reference Citation Analysis]
|
| 3 |
Lohiya DV, Pathak SS. Role of Technology in Detection of COVID-19. Cureus 2022. [DOI: 10.7759/cureus.29138] [Reference Citation Analysis]
|
| 4 |
Ferdausi N, Islam S, Rimti FH, Quayum ST, Arshad EM, Ibnat A, Islam T, Arefin A, Ema TI, Biswas P, Dey D, Azad SA. Point-specific interactions of isovitexin with the neighboring amino acid residues of the hACE2 receptor as a targeted therapeutic agent in suppressing the SARS-CoV-2 influx mechanism. J Adv Vet Anim Res 2022;9:230-40. [PMID: 35891654 DOI: 10.5455/javar.2022.i588] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Abiko Y, Paudel D, Uehara O. Hops components and oral health. Journal of Functional Foods 2022;92:105035. [DOI: 10.1016/j.jff.2022.105035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Mohamed FF, Anhlan D, Schöfbänker M, Schreiber A, Classen N, Hensel A, Hempel G, Scholz W, Kühn J, Hrincius ER, Ludwig S. Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2. Pharmaceuticals 2022;15:530. [DOI: 10.3390/ph15050530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 7 |
Mottaghipisheh J, Taghrir H, Boveiri Dehsheikh A, Zomorodian K, Irajie C, Mahmoodi Sourestani M, Iraji A. Linarin, a Glycosylated Flavonoid, with Potential Therapeutic Attributes: A Comprehensive Review. Pharmaceuticals (Basel) 2021;14:1104. [PMID: 34832886 DOI: 10.3390/ph14111104] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
|
